C21 Investments Inc (CXXIF)
0.2385
+0.02
(+8.41%)
USD |
OTCM |
Sep 19, 16:00
C21 Investments Price: 0.2385 for Sept. 19, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Sep 19, 2024 | 0.2263 | 0.2385 | 0.2263 | 0.2385 | 21220.00 |
Sep 18, 2024 | 0.248 | 0.248 | 0.22 | 0.22 | 17824.00 |
Sep 17, 2024 | 0.248 | 0.2497 | 0.232 | 0.235 | 12399.00 |
Sep 16, 2024 | 0.2419 | 0.243 | 0.2336 | 0.24 | 81250.00 |
Sep 13, 2024 | 0.236 | 0.2396 | 0.236 | 0.2396 | 21500.00 |
Sep 12, 2024 | 0.26 | 0.26 | 0.22 | 0.22 | 152642.0 |
Sep 11, 2024 | 0.2662 | 0.2662 | 0.25 | 0.25 | 24521.00 |
Sep 10, 2024 | 0.24 | 0.26 | 0.2302 | 0.252 | 54902.00 |
Sep 09, 2024 | 0.2425 | 0.252 | 0.2238 | 0.252 | 172548.0 |
Sep 06, 2024 | 0.225 | 0.225 | 0.215 | 0.225 | 37226.00 |
Sep 05, 2024 | 0.2475 | 0.2475 | 0.2475 | 0.2475 | 270.00 |
Sep 04, 2024 | 0.22 | 0.249 | 0.22 | 0.249 | 15074.00 |
Sep 03, 2024 | 0.22 | 0.2438 | 0.212 | 0.24 | 149601.0 |
Aug 30, 2024 | 0.2285 | 0.236 | 0.2226 | 0.2288 | 26294.00 |
Aug 29, 2024 | 0.22 | 0.2399 | 0.22 | 0.225 | 10925.00 |
Aug 28, 2024 | 0.23 | 0.23 | 0.23 | 0.23 | 49335.00 |
Aug 27, 2024 | 0.2335 | 0.24 | 0.2106 | 0.2151 | 226587.0 |
Aug 26, 2024 | 0.2596 | 0.26 | 0.2335 | 0.2335 | 3700.00 |
Aug 23, 2024 | 0.2468 | 0.2468 | 0.2468 | 0.2468 | 150.00 |
Aug 22, 2024 | 0.234 | 0.234 | 0.229 | 0.23 | 47300.00 |
Aug 21, 2024 | 0.26 | 0.2725 | 0.226 | 0.236 | 48460.00 |
Aug 20, 2024 | 0.2612 | 0.2725 | 0.2379 | 0.241 | 34365.00 |
Aug 19, 2024 | 0.275 | 0.2766 | 0.274 | 0.274 | 32091.00 |
Aug 16, 2024 | 0.2549 | 0.26 | 0.2549 | 0.26 | 9865.00 |
Aug 15, 2024 | 0.255 | 0.27 | 0.234 | 0.234 | 26972.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.165
Minimum
Mar 18 2020
1.97
Maximum
Feb 11 2021
0.4969
Average
0.38
Median
Price Benchmarks
Acasti Pharma Inc | 2.88 |
Aurinia Pharmaceuticals Inc | 7.20 |
Edesa Biotech Inc | 4.35 |
Lexaria Bioscience Corp | 3.15 |
Xenon Pharmaceuticals Inc | 40.92 |
Price Related Metrics
PS Ratio | 1.059 |
PEG Ratio | -0.0036 |
Price to Book Value | 0.9248 |
Price to Free Cash Flow | 22.89 |
Earnings Yield | -15.35% |
Market Cap | 28.63M |
PEGY Ratio | -0.0036 |
Operating PE Ratio | 375.07 |